Cancer Death Rates Higher for Children in Neighborhoods With Persistent Poverty

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 22, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, April 21, 2025 -- The risk for cancer death is higher among children diagnosed in neighborhoods marked by persistent poverty, according to a study published online April 21 in Pediatrics.

Emma Hymel, M.P.H., from the University of Nebraska Medical Center in Omaha, and colleagues used Surveillance, Epidemiology, and End Results-22 Registries Incidence Data with Census Tract Attributes Database data to examine the association between persistent poverty and early mortality and overall cancer-specific mortality among children from 2006 to 2020.

The study included 97,132 children; 12.63 percent resided in a persistent-poverty neighborhood at diagnosis. The researchers found that living in a persistent-poverty neighborhood was associated with a higher risk for early mortality and a higher risk for overall cancer death in adjusted models (adjusted hazard ratios, 1.26 and 1.15, respectively). For children with leukemias, central nervous system tumors, and hepatic tumors, persistent poverty was associated with overall cancer mortality (adjusted hazard ratios, 1.20, 1.14, and 1.36, respectively).

"Our findings contribute to a growing body of literature on the effect of social drivers of health on pediatric cancer outcomes," the authors write. "Further research is needed to identify multilevel interventions to mitigate disparities in pediatric cancer outcomes and to examine geographic differences in these disparities."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-22 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords